The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Joseph Saseen, PharmD, CLS

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits


This webcast will review several new nonstatin therapies that have been proven to reduce cardiovascular events, when added to statin therapy.

Learning Objectives

  1. Describe guideline and other expert recommendations of for the use of nonstatin therapy in the management of dyslipidemia
  2. Examine results from cardiovascular outcome trials evaluating non-statin therapies
  3. Review the mechanism of action, efficacy and safety of new and novel LDL-cholesterol lowering medications



This enduring material activity, The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins October 12, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Share this: